The stock of Huntsman (NYSE:HUN, 30-year Financials) is believed to be modestly overvalued, according to GuruFocus Value calculation. GuruFocus Value is GuruFocus' estimate of the fair value at which the stock should be traded. It is calculated based on the historical multiples that the stock has traded at, the past business growth and analyst estimates of future business performance. If the price of a stock is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher. At its current price of $27.22 per share and the market cap of $6 billion, Huntsman stock gives every indication of being modestly overvalued. GF Value for Huntsman is shown in the chart below.
Because Huntsman is relatively overvalued, the long-term return of its stock is likely to be lower than its business growth, which is estimated to grow 1.94% annually over the next three to five years.
Investing in companies with poor financial strength has a higher risk of permanent loss of capital. Thus, it is important to carefully review the financial strength of a company before deciding whether to buy its stock. Looking at the cash-to-debt ratio and interest coverage is a great starting point for understanding the financial strength of a company. Huntsman has a cash-to-debt ratio of 0.33, which is worse than 71% of the companies in Chemicals industry. GuruFocus ranks the overall financial strength of Huntsman at 5 out of 10, which indicates that the financial strength of Huntsman is fair. This is the debt and cash of Huntsman over the past years:
Companies that have been consistently profitable over the long term offer less risk for investors who may want to purchase shares. Higher profit margins usually dictate a better investment compared to a company with lower profit margins. Huntsman has been profitable 10 over the past 10 years. Over the past twelve months, the company had a revenue of $6.3 billion and earnings of $1.85 a share. Its operating margin is 5.24%, which ranks worse than 67% of the companies in Chemicals industry. Overall, the profitability of Huntsman is ranked 6 out of 10, which indicates fair profitability. This is the revenue and net income of Huntsman over the past years:
Growth is probably one of the most important factors in the valuation of a company. GuruFocus’ research has found that growth is closely correlated with the long-term performance of a company’s stock. If a company’s business is growing, the company usually creates value for its shareholders, especially if the growth is profitable. Likewise, if a company's revenue and earnings are declining, the value of the company will decrease. Huntsman’s 3-year average revenue growth rate is in the middle range of the companies in Chemicals industry. Huntsman’s 3-year average EBITDA growth rate is -5.9%, which ranks worse than 71% of the companies in Chemicals industry.
Another way to look at the profitability of a company is to compare its return on invested capital and the weighted cost of capital. Return on invested capital (ROIC) measures how well a company generates cash flow relative to the capital it has invested in its business. The weighted average cost of capital (WACC) is the rate that a company is expected to pay on average to all its security holders to finance its assets. We want to have the return on invested capital higher than the weighted cost of capital. For the past 12 months, Huntsman’s return on invested capital is 4.94, and its cost of capital is 7.62. The historical ROIC vs WACC comparison of Huntsman is shown below:
To conclude, The stock of Huntsman (NYSE:HUN, 30-year Financials) shows every sign of being modestly overvalued. The company's financial condition is fair and its profitability is fair. Its growth ranks worse than 71% of the companies in Chemicals industry. To learn more about Huntsman stock, you can check out its 30-year Financials here.
To find out the high quality companies that may deliever above average returns, please check out GuruFocus High Quality Low Capex Screener.